EGEPO.E — Nasmed Ozel Saglik Hizmetleri Ticaret AS Balance Sheet
0.000.00%
- TRY6.70bn
- TRY6.57bn
- TRY1.35bn
Annual balance sheet for Nasmed Ozel Saglik Hizmetleri Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | R2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 61 | 120 | 96.7 | 202 | 167 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 23.2 | 51.4 | 137 | 137 | 168 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 97.7 | 192 | 256 | 376 | 364 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 260 | 931 | 1,401 | 1,635 | 1,715 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 391 | 1,290 | 1,828 | 2,220 | 2,309 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 51 | 112 | 178 | 229 | 202 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 97.7 | 397 | 410 | 396 | 402 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 293 | 893 | 1,418 | 1,824 | 1,908 |
| Total Liabilities & Shareholders' Equity | 391 | 1,290 | 1,828 | 2,220 | 2,309 |
| Total Common Shares Outstanding |